To characterize blood miRNA patterns in mice with cancer, we utilized our previously described conditional transgenic mouse models of MYC-induced lymphoma, hepatocellular carcinoma and osteosarcoma [31-37]. This evidence concerns the gene MYC and hepatocellular carcinoma.